June 2017
Volume 58, Issue 8
ARVO Annual Meeting Abstract  |   June 2017
Glutathione is Required for Ocular Surface Development
Author Affiliations & Notes
  • Ying Chen
    Yale University, New Haven, Connecticut, United States
  • Nicholas Apostolopoulos
    Yale University, New Haven, Connecticut, United States
  • David Orlicky
    University of Colorado, Aurora, Colorado, United States
  • David M.G. Anderson
    Vanderbilt University, Nashville, Tennessee, United States
  • Kevin L Schey
    Vanderbilt University, Nashville, Tennessee, United States
  • David Thompson
    University of Colorado, Aurora, Colorado, United States
  • Richard A Lang
    University of Cincinnati Children's Hospital, Cincinnnati, Ohio, United States
  • Vasilis Vasiliou
    Yale University, New Haven, Connecticut, United States
  • Footnotes
    Commercial Relationships   Ying Chen, None; Nicholas Apostolopoulos, None; David Orlicky, None; David Anderson, None; Kevin Schey, None; David Thompson, None; Richard Lang, None; Vasilis Vasiliou, None
  • Footnotes
    Support  NIH grant EY021688
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1724. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ying Chen, Nicholas Apostolopoulos, David Orlicky, David M.G. Anderson, Kevin L Schey, David Thompson, Richard A Lang, Vasilis Vasiliou; Glutathione is Required for Ocular Surface Development. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1724. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Glutathione (GSH) maintains cellular redox balance and acts as a redox-signaling molecule. It is actively synthesized at millimolar levels in the developing eye during embryonic and early postnatal stages. The current study tests the hypothesis that GSH plays a pivotal role in the development of ocular surface.

Methods : We developed GclcLe/Le mice, a strain in which GSH biosynthesis is selectively abolished in surface ectoderm-derived ocular structures. Histology of eye tissues were examined at embryonic day (ED) 15, and post-natal days (PND) 1, 21 and 50. The ocular phenotypes were further characterized by Imaging Mass Spectrometry (IMS) and gene expression analysis around PND25.

Results : GclcLe/Le embryos at ED15 had normal development of ocular surface tissues, including lens, cornea, conjunctiva, and eyelids. At birth (PD1), GclcLe/Le mice show defective lens featuring poor differentiation and vacuolation of fiber cells. Abnormalities in other ocular structures, including the cornea and retina, were not observed until PD21. GclcLe/Le mice exhibited bilateral small eyes (microphthalmia) by PD21. IMS examination of the whole eyes around this age revealed distinct changes in the lipid and protein profiles in the GclcLe/Le ocular tissues relative to control eyes. Panels of genes involved in regulation of eye development (SOX2 and SIX3), signal transduction (NOTCH1, CATNB and FGF7) and stress response (PTEN, NRF2, and HMOX1) were found to be differentially altered in a tissue-specific manner in GclcLe/Le eyes.

Conclusions : Our results show that GSH plays a critical role in ocular development, likely by regulating multiple molecular pathways. Further studies are underway to identify molecular details involved in this process.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.